Author of the publication

Inhibition of HER3 activation and tumor growth with a human antibody binding to a conserved epitope formed by domain III and IV

, , , , , , , , , , and . mAbs, 9 (5): 831--843 (July 2017)
DOI: 10.1080/19420862.2017.1319023

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Superior properties of Fc-comprising scTRAIL fusion proteins, , , , , , , and . Molecular Cancer Therapeutics, 16 (12): molcanther.0551.2017 (December 2017)Expression and Purification of Recombinant Antibody Formats and Antibody Fusion Proteins, , , , and . Methods in molecular biology (Clifton, N.J.), 1131, (2014)Inhibition of HER3 activation and tumor growth with a human antibody binding to a conserved epitope formed by domain III and IV, , , , , , , , , and 1 other author(s). mAbs, 9 (5): 831--843 (July 2017)Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activity, , , , , , and . mAbs, 11 (1): 166-177 (2019)A Fab-Selective Immunoglobulin-Binding Domain from Streptococcal Protein G with Improved Half-Life Extension Properties, , , and . PLOS ONE, 10 (10): e0139838 (2015)Immunoliposomes for Targeted Delivery of an Antifibrotic Drug, , , , , and . Molecular pharmaceutics, 12 (9): 3146-3157 (2015)The IgM CH2 domain as covalently linked homodimerization module for the generation of fusion proteins with dual specificity, , , , , , and . Protein Engineering, Design and Selection, 25 (10): 603--612 (October 2012)Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activity, , , , , , and . mAbs, (September 2018)Preclinical efficacy of endoglin-targeting antibody-drug conjugates for the treatment of Ewing sarcoma, , , , , , , , , and 16 other author(s). Clinical Cancer Research, (November 2018)Superior Properties of Fc-comprising scTRAIL Fusion Proteins, , , , , , , and . Molecular cancer therapeutics, 16 (12): 2792-2802 (2017)